Verona Pharma

Acquired

Innovative Respiratory Treatments

Verona Pharma is headquartered in London, United Kingdom and lists 51–200 employees.

Headquarters
London
Employees
51–200
Business Model
B2B

Indexed holds 5 investors for this company. The full record is or through the API.

About

Verona Pharma was a clinical-stage biopharmaceutical company headquartered in London, UK, with US offices in Raleigh, NC and Savannah, GA, focused on developing and commercializing novel treatments for chronic respiratory diseases including COPD, asthma, and cystic fibrosis. The company's lead product, Ohtuvayre (ensifentrine), became the first inhaled therapy for COPD maintenance treatment combining bronchodilator and non-steroidal anti-inflammatory activities in a single molecule. Verona Pharma was acquired by Merck in 2025 for approximately $10 billion.

Summary

Verona Pharma is a Biotech company based in London, United Kingdom. It lists 51–200 employees. Investors include Oaktree Capital Management, RA Capital Management and OMERS Life Sciences.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Exit History

Debt FinancingDebt FinancingMay 2024
$650.0M

Sign up to see all 4 events

Funding, valuations, and company events, with amounts and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Verona Pharma on Indexed.vc
<a href="https://indexed.vc/companies/verona-pharma"><img src="https://indexed.vc/api/badge/company/verona-pharma" alt="Verona Pharma on Indexed.vc" width="260" height="76" /></a>